EMAIL THIS PAGE TO A FRIEND

PloS one

FGFR2 is amplified in the NCI-H716 colorectal cancer cell line and is required for growth and survival.


PMID 24968263

Abstract

Aberrant kinase activation resulting from mutation, amplification, or translocation can drive growth and survival in a subset of human cancer. FGFR2 is amplified in breast and gastric cancer, and we report here the first characterization of FGFR2 gene amplification in colorectal cancer in the NCI-H716 colorectal cancer cell line. FGFR2 is highly expressed and activated in NCI-H716 cells, and FGFR selective small molecule inhibitors or FGFR2 shRNA strongly inhibited cell viability in vitro, indicating "addiction" of NCI-H716 cells to FGFR2. NCI-H716 growth in a xenograft model was also inhibited by an FGFR small molecule inhibitor. FGFR2 was required for activation of multiple downstream signaling proteins including AKT, ERK, S6RP and NFKB. Inhibition of downstream kinases such as AKT or ERK alone had modest effects on proliferation, whereas combined inhibition of AKT and ERK signaling resulted in a loss of viability similar to FGFR2 inhibition. We identified elevated FGFR2 expression in a small subset of primary colorectal cancer, however FGFR2 amplification was not observed. Although FGFR2 amplification is not common in primary colon cancer or lymph node and liver metastases, other subsets of colorectal cancer such as ascites, from which the NCI-H716 cell line was derived, have yet to be tested. These results suggest that emerging FGFR inhibitor therapeutics may have efficacy in a subset of colon cancer driven by FGFR2 amplification.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

GW21062 Anti-CD221 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB2500395
Anti-FGFR2 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1412031
ANTI-FGFR2 antibody produced in mouse, clone 3F4, purified immunoglobulin, buffered aqueous solution
HPA035305
Anti-FGFR2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4500889
Anti-FGFR2 antibody produced in rabbit, affinity isolated antibody
SAB4300359
Anti-IGF1R (Ab-1161) antibody produced in rabbit, affinity isolated antibody
SAB4300360
Anti-IGF1R (Ab-1165/1166) antibody produced in rabbit, affinity isolated antibody
SAB4300548
Anti-IGF1R (Ab-1280) antibody produced in rabbit, affinity isolated antibody
SAB4300549
Anti-IGF1R (Ab-1346) antibody produced in rabbit, affinity isolated antibody
SAB2101136
Anti-IGF1R antibody produced in rabbit, affinity isolated antibody
SRP4038 Fgf-2 from mouse, recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC)
SRP4039 Fgf-2 from rat, recombinant, expressed in E. coli, ≥97% (SDS-PAGE), ≥97% (HPLC)
WH0002263M1
Monoclonal Anti-FGFR2 antibody produced in mouse, clone 1G3, purified immunoglobulin, buffered aqueous solution
SAB1403815
Monoclonal Anti-FGFR2 antibody produced in mouse, clone 2C11, purified immunoglobulin, buffered aqueous solution
SAB5300081
Monoclonal Anti-IGF1R antibody produced in mouse, clone 3C8B1, ascites fluid
SAB5300082
Monoclonal Anti-IGF1R antibody produced in mouse, clone 3G5C1, ascites fluid